Indications and uses
Apply twice daly(morning and night as a man and once as a woman.Afer apicaion, proeed with an acive massage for 3-5 minutes unlthe product is fuy absorbed
Apply twice daly(morning and night as a man and once as a woman.Afer apicaion, proeed with an acive massage for 3-5 minutes unlthe product is fuy absorbed
For external use only.
Salicylic acid 2%
wart remover
Apply twice daly(morning and night as a man and once as a woman.Afer apicaion, proeed with an acive massage for 3-5 minutes unlthe product is fuy absorbed
Forevemaluseony Avoid coniac wth eves li coniac ocus nse ihorouthly wt waier Keep out ofreach oi chidrenifvou ale preanant.nursing. otiaveanyunderving medca condion.consutyou healthcare provider before using the product.
For external use only.
Discontinue use if any irritation or adverse reaction occurs
When using this product, avoid contact with eyes. lf contact occurs, rinse thoroughly with waterDiscontinue use if any irritation or adverse reaction occurs.
on broken or irritated scalp
If sxralowed, get medical help or contact a Poison Conirol Cenler ngiht away.
Acrylates copolymer, Ethyl acetate
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84369-031 | 84369-031-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ETHYL ACETATE | 76845O8NMZ | IACT |
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1d2000b4-f104-e8d0-e063-6394a90ad1ad | 1d2000b4-f103-e8d0-e063-6394a90ad1ad | 2024-07-13 | Warnings | 1d2000b4-f104-e8d0-e063-6394a90ad1ad 1d2000b4-f103-e8d0-e063-6394a90ad1ad |
Adverse event summaries are temporarily unavailable. Other product information remains available.